Urol. praxi, 2014; 15(2): 80-81

Aragonite urolithiasis

MUDr.Martin Kučera
Urologické oddělení Nemocnice Kyjov

Aragonite is considered to be rare in mineralogical analysis of urinary calculi. It’s often interpreted as an artifact in a mixture of other

crystals of the calculi. We present a case of patient with 16 stones formed by aragonite. Common investigative procedures failed to detect

certain metabolic disorder and therefore metaphylaxis and treatment fail.

Keywords: aragonite, urolithiasis, calcium carbonate, lithostatin

Published: April 21, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kučera M. Aragonite urolithiasis. Urol. praxi. 2014;15(2):80-81.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bartoníčková K, Horáčková M. Etiologie, diagnostika a léčba urolitiázy - aspekty urologické a nefrologické. Aktual. v Nefrol., 2005; 11(2-3): 73-76.
    2. Kawaciuk I. Urologie. 1. vyd. Praha: Galén, 2009. 303-332.
    3. Sobotka R, Hanuš T. Příčiny a rizikové faktory vzniku urolitiázy. Urol. praxi, 2012; 13(1): 11-15.
    4. Daudon M, Donsimoni R, Hennequin C, et al. Sex- and age-related composition of 10 617 calculi analyzed by infrared spectroscopy. Urol Res. 1995; 23: 319-326. Go to original source... Go to PubMed...
    5. Miller NL, Lingeman JE. Management of kidney stones. BMJ. 2007; 334: 468-472. Go to original source... Go to PubMed...
    6. Schubert G. Stone analysis. Urol Res. 2006; 34: 146-150. Go to original source... Go to PubMed...
    7. Leusmann DB, Blaschke R, Schmandt W. Results of 5,035 stone analyses: a contribution to epidemiology of urinary stone disease. Scand J Urol Nephrol. 1990; 24: 205-210. Go to original source... Go to PubMed...
    8. Ulusan S, Koc Z. Milk of calcium collection in the differential diagnosis of giant renal calculus. Br J Radiol. 2008; 81: 35-36. Go to original source... Go to PubMed...
    9. Uesugi T, Ichikawa T. Atypical findings in a patient with a renal milky stone including a cake of stone. Int J Urol. 2006; 13: 1109-1111. Go to original source... Go to PubMed...
    10. Dítě P, Trna J, Floreanová K, Geryk E. Chronická pankreatitida. Med. Prax. 2011; 8 (11): 455-458.
    11. Deganello S, Asplin J, Coe FL. Evidence that tubule fluid in the thin segment of the loop of Henle normally is supersaturated and forms a poorly crystallized hydroxyapatite that can initiate renal stones. Kidney Int. 1990; 37: 472.
    12. Coe F, Parks JH. Defenses of an unstable compromise: Crystallization inhibitors and the kidney's role in mineral regulation. Kidney Int. 1990; 38: 625-631. Go to original source... Go to PubMed...
    13. Verdier JM, et al. Renal nithostatine: a new protein inhibitor of lithogenesis. Nephrologie 1993; 14 (6): 261-264 (PubMed). Go to PubMed...
    14. Veider JM, et al. Evidence that human kidney produces a protein similar to lithostatine, the pancreatic inhibitor of CaCO3 crystal growth. Eur J Clin Invest 1992; 22 (7): 469-474 (PubMed). Go to original source... Go to PubMed...
    15. Geider S, et al. Calcium carbonate crystals promote calcium oxalate crystallization by heterogeneous or epitaxial nucleation: possible involvement in the control of urinary lithogenesis. Calcif Tissue Int. 1996; 59(1): 33-37 (PubMed). Go to original source... Go to PubMed...
    16. Kontoyannis ChG, Vagenas NV. Calcium carbonate phase analysis using XRD and FT-Raman spectroscopy. Royal Soc. Chem. 2000; 125: 251-255. Go to original source...
    17. Cowan JC, Weintritt DJ. Water-Formed Scale Deposits. Houston: Gulf Publishing Co., 1976; 97-108.

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.